were performed in a population of 422.5 million, corresponding to 850 cycles per million inhabitants. For IVF, the clinical pregnancy rates per aspiration and per transfer were 29.0 and 32.4%, respectively. For ICSI, the corresponding rates were 29.9 and 33.0%. After IUI-H the delivery rate was 9.2% in women below 40. After IVF and ICSI the distribution of transfer of one, two, three and four or more embryos was 22.1, 57.3, 19.0 and 1.6%, respectively. Compared with 2005, fewer embryos were replaced per transfer, but significant national differences in practice were apparent. The proportion of singleton, twin and triplet deliveries after IVF and ICSI combined was 79.2, 19.9 and 0.9%, respectively. This gives a total multiple delivery rates of 20.8% compared with 21.8% in 2005 and 22.7% in 2004. IUI-H in women below 40 years of age resulted in 10.6% twin and 0.6% triplet pregnancies.
Introduction
This report is the 10th annual European Society of Human Reproduction and Embryology (ESHRE) publication on European data on assisted reproductive technology (ART). The nine previous reports, also published in Human Reproduction (ESHRE, 2001a (ESHRE, , b, 2002 (ESHRE, , 2005 (ESHRE, , 2006 (ESHRE, , 2007 (ESHRE, , 2008 (ESHRE, , 2009 , covered treatment cycles from 1997 to 2005. This year, the printed version only contains the four most important tables; additional tables are available online, making the whole report consistent with those from previous years, whereas also including additional material. In the published report, these tables will be referred as 'Supplementary Data, Table SI -SXVIII'. The main results of this report were presented at the annual ESHRE congress in Amsterdam July 2009.
Materials and Methods

Data collection
Data on ART have been collected from 32 European countries, covering IVF, ICSI, frozen embryo replacement (FER), egg donation (ED), in vitro maturation (IVM), pooled data on preimplantation genetic diagnosis (PGD) and screening (PGS) and frozen oocyte replacements (FOR) . In addition to ART, data on intrauterine inseminations using husband/partner's semen (IUI-H; 20 countries) and donor semen (IUI-D; 18 countries) were also included. The report includes treatments started between the 1st of January and the 31st of December 2006. Follow-up data on pregnancies and deliveries are cohort data, based on the reported cycles.
Following agreement of the consortium in Barcelona in 2008, the reporting forms used for 2006 data were expanded in comparison to those from previous years. A module describing the reporting methods has been added. The form on women's age now reports cycle outcome (pregnancies and deliveries) in relation to age. Multiple deliveries are reported according to the number of transferred embryos. The form on IUI now includes deliveries and multiple deliveries. Finally, an optional module was added to report the gestational age according to the number of infants per delivery.
As in previous years, data were directly entered in the ESHRE computer by each country coordinator, through software developed by ESHRE and modified according to the new forms. Data analyses were performed in ESHRE headquarters by V. Goossens.
Results
Participation
This report includes data from three more countries (Austria, Cyprus and Latvia) and one fewer (Croatia) than the 2005 report (Table I) . The proportion of reporting clinics rose to 86.0% (998 out of 1160 clinics), in comparison to 81.4% in 2005 (923 out of 1134) . In 20 countries, the coverage reached 100%, seven more than in 2005 (Austria, Cyprus, Czech Republic, Germany, Italy, Latvia and Turkey). In two other countries, the number of participating clinics also increased substantially (from 4 to 15 in Bulgaria, 1 to 4 in Serbia), but participation still remained very low in two countries (Greece and Serbia) and limited in four others (Bulgaria, Hungary, Poland and Spain).
Number of treatment cycles
In total, 458 759 cycles were reported, 40 648 more than in 2005 (+9.7%). Among the 350 162 fresh cycles (+9.1%), there were 117 318 IVF (20.1%) and 232 844 ICSI (+14.5%). The proportion of ICSI thus reached 66.5% of 'fresh ' ART cycles (63.3% in 2005) . The proportion of FER cycles compared with 'fresh' cycles was 24.6%. The number of ED increased in the same proportion, reaching 12 685 (+10.5%), reported by 22 countries, the main contributor being Spain (6547 cycles). PGD was recorded from 13 countries (6561 cycles, +12.2%). IVM was reported at the same low level (247 cases) as in 2005. Finally, 3498 FOR cycles were newly reported, the majority from Italy (85.1% of cases). 
Reporting methods and size of the clinics
Among the 20 countries with complete reporting (Supplementary Data, Table SII), the register was compulsory for 14 (11 held by a National Health Authority (NHA) and 3 by a medical organization (MO)] and voluntary for 6 (5 held by a MO and 1 by an health care insurance). Only six registers were based on individual forms. Among the 12 countries with partial coverage, only three were held by an NHA and only one was based on individual forms.
The distribution of clinics according to the number of cycles varied considerably among the countries (Supplementary Data, Table SIII ). For example, it could be noted that in Italy 46% of the clinics provided fewer than 100 cycles annually, whereas in Belgium and Sweden 50% of the clinics performed more than 1000 cycles a year. In the Netherlands (where satellite stimulated cycles are frequent), 62% of the clinics handling gametes performed more than 1000 cycles annually. Table II shows pregnancy and delivery rates per aspiration for IVF, ICSI and FER. Only one country provided outcome per embryo transfer, whereas four others were unable to provide data on deliveries. Thus, the mean pregnancy rate and delivery rate were computed for countries providing the relevant information. There were huge variations across the countries. On average, the pregnancy rates were 29.0% (+2.0% compared with 2005) and 29.9% (+1.4%) per aspiration for IVF and ICSI, and 19.1% per thawing for FER (+0.1%). Mean delivery rates per aspiration/thawing were 21.5, 18.4 and 12.7%, respectively. The detailed numbers of cycles, aspirations, transfers, pregnancies, deliveries and the corresponding rates per technique are reported in Supplementary Data, Tables SIV for  IVF, SV for ICSI and SVI for FER. In total, 87 705 babies were recorded to be born from in the 28 countries where the reporting from IVF, ICSI and FER included newborns. In countries with complete reporting, the percentage of babies conceived through ART varied from 1.0% of the national births in Italy to 4.1% in Denmark. More details are provided in Supplementary Data, Ireland, Italy, Macedonia, Montenegro, Serbia and Switzerland), whereas it was ,10% in Bulgaria, Czech Republic, Lithuania, Norway, Poland, Portugal, and Ukraine. As expected, pregnancy rates decreased with age, from 28.2% through 22.2% to 9.6% for women aged ≤34, 35 -39 and ≥40 years, respectively. The same trend was seen for delivery rates (26.6, 20.5 and 8.6% 
Pregnancies and deliveries after treatment
Number of embryos transferred and multiple deliveries
Risks and fetal reductions
Supplementary Data, Table SXIV shows the risk of preterm deliveries according to the number of newborn. Data were available from 17 countries. It clearly shows that the risk of extremely preterm birth rate (gestational week 20-27) increases from 0.8% for a singleton delivery, to 2.6% for twins and 7.4% for triplets. The same trend was noted for very preterm (28 -32 weeks), from 2.5 to 11.0% and 37.4%, respectively, and for preterm (33 -36 weeks), from 8.7 to 39.3 and 43.9%, respectively.
Ovarian hyperstimulation syndrome (OHSS) was reported in 27 of the 32 countries (Supplementary Data, Table SXV ). In total, 2753 cases of OHSS were recorded, corresponding to a risk of OHSS of 0.8% (1.2% in 2005) of all stimulated cycles. The table also includes other complications, such as fetal reductions (n ¼ 466).
Preimplantation genetic diagnosis and screening
PGD/PGS activity was recorded from 13 countries (Table I) 802 deliveries (14.0% per aspiration), the main contributors being Spain (2478 cycles) and Turkey (2308 cycles).
In vitro maturation
IVM was recorded in eight countries (Table I) . A total of 241 aspirations were recorded, resulting in 32 pregnancies and 20 deliveries (8.3% per aspiration). Table SXVII ). For France no stratification for age was available. In IUI-H, the delivery rate declined with age (9.2% below 40 versus 4.1% above), and multiple deliveries slightly decreased (from 10.6 to 8.9% for twins and from 0.6 to 0.0% for triplets). Similar findings were seen in IUI-D, where delivery rates decreased from 13.3 to. 4.1%, twin deliveries from 10.5 to 6.5% and triplets from 0.6 to 0.0%.
Intrauterine inseminations
Cumulative delivery rates
Supplementary Data, Table SXVII gives an estimation of the cumulative delivery rates per initiated fresh stimulated cycle. This is not the real cumulative delivery rate per couple per cycle, but shows the number of deliveries obtained from the FER cycles added to the deliveries from the stimulated cycles during the same year. Additionally the table shows the rate of multiple deliveries after the 'fresh' cycles and the FER combined. It shows that adding the deliveries after FER increases the delivery substantially (Finland +11.3%, Iceland +10.2%, Sweden +7.9% and Switzerland +9.2%). The overall multiple delivery rate in Finland, Iceland and Sweden were low: 7.5, 13.9 and 5.9%, respectively.
Discussion
The present report is the 10th consecutive, annual European report on ART data. Together these reports cover treatment cycles from 1997 to 2006. It can be argued that as long as data are incomplete, lack uniformity in terms of clinical definitions and are generated through different methods of data collection, they should be interpreted carefully. Therefore, the focus should primarily be on specific country data rather than on summary data. This year, data capture forms have been expanded in order to allow comparisons with data from previous years and to make them more consistent with the forms used by International Committee Monitoring Assisted Reproductive Technologies (ICMART) in the world report. The latter is important since European data represent more than half of all cycles reported in the world report. The new forms also contain more information on multiple pregnancy risks in ART.
As is evident from the tables, registers from a number of countries have been unable to provide some of the data. In order to standardize definitions and reporting the ICMART glossary has been published (Zegers-Hochschild et al., 2006a, b) , and recently revised with WHO (Zegers-Hochschild et al. 2009a, b) . These recommendations could not have been implemented in all countries in 2006 where the treatments were done, and even if they had, interpretation of the data must still be done with caution.
In 2006, the number of countries reporting to ESHRE's EIM Consortium increased to 32 countries covering the whole of Western Europe. Austria, Cyprus, and Latvia joined the consortium. In Eastern and South Eastern Europe, no data were still available from Estonia, Bosnia, Romania and Slovakia. Moreover, Croatia was unable to give data for 2006.
For 2006, data quality improved, since seven more countries than in 2005 were able to provide full coverage. Moreover, even if still incomplete, 86.0% of all clinics participated, almost 5% more than in 2005. For example, Turkey was able to give a full report, making this country the sixth contributor in relation to number of cycles. Additionally, those clinics that do not report are likely to be smaller in size than those that do report. In Greece only 9 of 50 clinics provided a report, however, efforts are being made to establish a statutory register.
Overall, the number of reported cycles reached 458 759 cycles, and thus increased 9.1% compared with 2005. A part of this increase was due to the fact that more clinics reported data. The present report also includes data from almost 160 000 IUI cycles, 10 000 more than in 2005. Within Europe, the largest number of ART cycles were reported from France (66 000), Germany (55 000), Spain (50 000), the UK (44 000) and Italy (41 000). In comparison, in 2006, 138 198 cycles were reported from the USA (CDC, 2008) , and 53 543 cycles from Australia and New Zealand (AIHW, 2008) .
Reduction in the re-imbursement for ART resulted in a sharp decline in the number of cycles from Germany between 2003 and 2004 (from 102 000 to 57 000), which continued in 2005 (53 000). The present data from 2006 show a marginal increase (almost 55 000 cycles). The German example provides good evidence that a public re-imbursement policy of ART has a major impact on the number of treatments.
As shown in Table I in countries with a full report, the average number of treatment cycles per million inhabitants ranged from 122 in Latvia to 2268 in Denmark. A better way to define the availability of ART is to report ART cycles in women of reproductive age (15 -49 years), which eliminates the impact of age differences across the countries (Table I) . Again, there were huge differences, from 475 cycles per million women in Latvia, to 10 132 in Denmark (Table I) . Finally, the percentage of newborns conceived through ART varied from 0.8% in Montenegro to 4.1% in Denmark (Table II) . It is difficult to explain those differences that may be related to several factors like cost, re-imbursement, legal or sociological aspects, and medical strategies in the use of ART to infertile couples. These factors also may play some role in the differences observed in pregnancy and delivery rates between countries, ... ............................................................................................................... ..................................................................................................................   ..................................................................................................................................................................................................................................................... ..... The proportion of ICSI versus standard IVF procedures continues to increase (49% in 2004, 63% in 2005 and 66.5% in 2006) . A similar trend has been observed in the USA (Jain and Gupta, 2007) . As recently reviewed, the trend towards increased use of ICSI has been observed throughout the world (Nyboe Andersen et al., 2008; ICMART, 2009) . In Australia and New Zealand, 58.5% of all cycles used ICSI in 2006 and in the USA the corresponding figure was 62.3%, so there is a uniform development in those three regions. However, within Europe a marked variation exist regarding the distribution between IVF and ICSI. As can be seen in Table 1 , 11 countries used ICSI in more than 75% of cases, the highest being Turkey (97.2%). In contrast, in the Nordic countries, the Netherlands, Russia, Ukraine, Ireland, the UK and a few other countries, IVF remain the dominant technology. As recently analysed (Nyboe Andersen et al., 2008) , the marked increase in the use of ICSI cannot be explained by a similar increase in male infertility but rather to a more frequent use of ICSI in cases with mixed caused of infertility, unexplained infertility and mild male factor infertility. This is, however, unlikely to fully account the differences between the countries, which can only be explained by different professional approaches.
The number of embryos transferred in IVF and ICSI cycles differed substantially between countries, but there is a clear trend during the years of observation towards transfers with fewer embryos (Table III) This report is unable to define the number of elective SET (eSET) versus SET but the rise in the number of transfers of one embryo is undoubtedly due to a rise in eSET. As seen in Table III there were four countries that reported transfer of a single embryo in more than 45% of all transfers: Sweden (69.6%), Finland (54.7%), Belgium (49.2%) and Norway (48.0%), all with an increase from 4 to 6% since 2005. For comparison single embryo transfer was done in 62 and 40% of cycles in Australia and New Zealand for women aged less than 38 years or 38 or more, respectively (AIHW, 2008) .
The consistent trend towards transfer of fewer embryos is also reflected in the overall occurrence of multiple deliveries after IVF and ICSI. In 2000, the average multiple delivery rate was 26.9%, declining to 24.5% in 2002, 21.8% in 2005 and now 20.8% in 2006 . During the 10 year period of EIM reporting the most remarkable finding regarding multiples has been the reduction in triplet deliveries from 3.6% in 1997 to 0.9% in 2006. As it is evident from Table III, however, major differences in triplet rates are still evident across countries. We have included data describing preterm birth rates according to the number of fetuses of the pregnancy (Supplementary Data, Table SXIV ). It was completed by half of the reporting countries. The risk of extreme preterm birth (,28 weeks) was increased 3-fold for twins and by almost 10-fold for triplets. The risk of very preterm (28 -32 weeks) birth are increased almost 5 for twins and 15-fold for triplets.
Fetal reductions are almost always only done in triplet or higher order gestations. Thus, when analysing the range of triplet delivery rates in different countries, the number of fetal reductions should also be considered. A total of 466 procedures were reported, the largest numbers coming from the UK (102), Spain (95), Czech Republic (89) and Ukraine (78). However, the total number is likely to be an underestimate since several countries, including large countries as Germany and France did not report them in 2006. Without this intervention, the proportion of triplet deliveries would have been higher, given that a number of countries did not report on fetal reductions, and that the number reported is higher than the number of recorded triplet deliveries (230 in Table SXI ). Those tables also give the delivery rates per cycle. These tables are important to consider since they better allow comparing the countries, as age is a major prognostic factor that is unequally distributed across the countries.
With the noticeable decline in the number of embryos transferred, the cumulative delivery rate per started cycle may be a most relevant endpoint for ART (Supplementary Data, Table SXVIII ). In fact, the calculation of this cumulative delivery rates is not methodologically correct since it simply adds the fresh and FER pregnancies obtained in the same year rather than the FER pregnancies accruing from one oocyte aspiration procedure. It should, however, be stressed that the correct figure can only be obtained a few years after the initial oocyte aspiration and, in a steady state situation this calculation will give a reasonable estimate of the true cumulative delivery rate. In several countries the addition of FER deliveries added a substantial increase to the delivery rates per cycle: Finland (20.6-31.9%), Sweden (23.1-31.0%) and Switzerland (17.0-26.2%), justifying the transfer and freezing policies performed in those countries.
PGD/PGS activity was recorded from 13 countries and included 6561 cycles resulting in 802 deliveries (14.0% per aspiration). Detailed analysis of PGD/PGS in Europe will be published separately by ESHRE's PGD Consortium (Sermon et al., 2007) .
The major differences between countries in the numbers of some techniques, such as ED or PGD, must be viewed as markers of crossborder reproductive care: couples who do not have access to ART in their home countries and travel to another country to get treated. This phenomenon raises important public health questions needing more information for proper evaluation, which will be addressed by EIM in the next future.
Regarding direct risks of ART, OHSS was recorded in 0.8% of cycles; less than in 2005 (1.2%). This could be due to a possible increased use of milder stimulation in Europe, changes in triggering of ovulation, and/or an underreporting of OHSS.
For the fifth consecutive year the present report includes European data on treatments with IUI-H (134 000 cycles) and IUI-D (24 000 cycles), thus showing an increase in IUI-H (+6000) and in IUI-D (+3000), compared with 2005. The coverage of IUI activities by the national registers is less comprehensive than for the in vitro techniques. In women below 40 years of age the delivery rate was 9.2% for IUI-H and 13.3% for IUI-D.
After IUI, both for husband and donor insemination, twin pregnancies were observed in approximately half as many cases compared with after ART, but triplet pregnancies were at similar rates.
In summary, the present 10th ESHRE report on ART for Europe in 2006 shows a continuing expansion of numbers of participating clinics, countries and treatment cycles reported. The rise in the use of ICSI continued and reached 66.5% in 2006. Pregnancy rates after IVF and ICSI showed marginally increase compared with 2005, although fewer embryos were transferred and SET reached 22.2% in 2006. As a consequence the multiple delivery rates continued to decline to 20.8% of all deliveries after IVF and ICSI.
